Switching Pet Supplement Suppliers: A Product Transfer Checklist
Share
The failure most often underestimated when switching pet supplement manufacturers isn't "they can't make it" — it's "what they make no longer matches the original product." Sensory drift, non-compliant labels, missing traceability records on the first new-source batch: any one of these can cost a brand a full batch return or a redesign.
Before changing manufacturing partners, the first question isn't "can they make the same product?" It's: which materials is the brand allowed to share, which product characteristics must be preserved, and which differences are acceptable.
A promoted article on human supplement contract manufacturing describes cases where a formulation behaves differently in the lab and at production scale, including color changes and shifts in dissolution performance (Nutraceutical Business Review, October 2026). This is a reason for a transfer team to define sensory and specification benchmarks, then verify them under the new manufacturing path. Before approving a new manufacturing path, put the approved product benchmark and the new supplier's proposal side by side.
This checklist is for brands transferring an existing pet supplement to a new contract manufacturer. It helps teams prepare the handover and track open items. The new manufacturer, along with the people responsible for quality, labeling, and target markets, still needs to evaluate the product and process for each specific project.
On this page
Three Decisions Before Sharing Pet Supplement Transfer Documents
1. Decide what you are allowed to share.
List everything you hold: formulas, ingredient specifications, test methods, process descriptions, packaging artwork, supplier information, and historical results. Check item by item who created it, who controls it, and what your agreements permit you to disclose to another manufacturer — or use at all. Before transferring restricted materials, agree on the recipient, the purpose, and confidentiality arrangements.
A cross-industry technology transfer article notes that the outgoing and incoming manufacturers may be competitors, and confidentiality constraints can restrict the flow of information between technical teams; important operating information may therefore be left out (Pathway2Product: How to Write a Technology Transfer Protocol).
A brand may own its packaging artwork and reference samples yet have no right to transfer the original manufacturer's full process or base formula. Check the actual agreements; the project label "OEM" or "private label" alone does not determine who owns what.
2. Define the benchmark for the existing product.
Select the approved product version; where possible, link it to traceable production batches and retained samples. Record the target species, dosage form, serving size, ingredient and packaging versions, sensory characteristics, release specifications, storage conditions, and current label. Mark which features the brand must preserve and which can be renegotiated. If old records are incomplete, document the gaps — and never treat a finished product sample as a complete formula or set of production instructions.
3. Set the decision rules in advance.
Define who approves formula changes, samples, testing, packaging, and the final switch. Before evaluating new samples, agree on the comparison method and acceptance criteria. Similar appearance is only an observation; which ingredient, performance, safety, or shelf-life checks the product actually needs must be judged product by product.
A footnote from practice: in Anivor's own feasibility assessments, we have rejected formulas brought to us — some active-ingredient amounts did not pass the dog-and-cat safety assessment used for those projects, while other novel ingredients did not meet the entry requirements of the projects' target markets. We did not proceed with the original proposals. If such problems reach the market with a product, the brand on the label can also face compliance and safety risks. Writing down "what can be made, and who decides" in advance is how these decisions get made before shipment, not after.
One principle worth recording early: the manufacturer evaluates feasibility and actually produces; the brand and its designated quality or target-market professionals approve the relevant targets and decisions. The earlier this boundary is made explicit, the fewer disputes later.
Case sources (Chinese)
Six Categories of Pet Supplement Transfer Materials
| Category | Collect or confirm | Questions to ask the new manufacturer |
|---|---|---|
| Rights & versions | Sharing permissions for each document; approved versions of formulas, specifications, samples, and artwork; document owner and date | Which materials do you need for feasibility assessment, and who will see them? |
| Formula & ingredients | Available ingredient identities, grades/specifications, suppliers or permitted alternates, dosage basis, and per-serving targets | Which ingredients can you source to the specified grade? What do you propose to substitute? |
| Process & dosage form | Known process steps, critical process constraints, and dosage form requirements; flag undisclosed process steps separately | Which steps can you execute? Which require redevelopment or validation? |
| Product & quality benchmark | Approved appearance, dimensions or unit weight, sensory references, applicable test methods, limits, COA (certificate of analysis), and batch records | Which attributes and release conditions can you compare against the reference? |
| Packaging & labeling | Packaging materials, fill weight or count, seals, artwork versions, storage instructions, and market-facing claims | Does the new proposal or a change of production site require a review of packaging, labels, or claims? |
| Supply & transition | Current batch numbers, inventory, open orders, target switch date, approvers, and change-record owner | Before the first new-source order, what evidence and approved versions are required? |
When requesting documents, applicability must match the specific product, version, and batch. A certificate or COA from another product, facility, or batch does not verify this transfer. FDA's guidance on animal food production controls and receiving/shipping records varies with facility activities and applicable exemptions; the EU framework covers feed hygiene and traceability. These resources remind the team to clarify "who checks the requirements for the target market." See FDA's guide for animal food businesses, the European Commission's feed hygiene overview, and its traceability requirements. Industry self-regulation offers a further reference point: The National Animal Supplement Council (NASC) FAQ says members must report monthly whether or not they have an adverse event; its 2008 publication reported about 0.31 adverse events per million administrations for member products at that time, based on member reports (NASC's response to the NRC report, 2008).
For how Anivor coordinates specifications, batch records and testing inputs, see our quality and documentation support.
Compare Pet Supplement Attributes by Dosage Form
A transfer brief must describe what the customer actually experiences, not just the formula on paper. For tablets, ask how size, appearance, hardness, dusting or chipping, coating, and shipping protection are evaluated. For soft chews, compare unit size, firmness, color, odor, surface oil, and changes during storage. These attributes provide a shared language for negotiating specifications. For powders, compare flow, clumping, color, odor, dispensing and mixing behavior under agreed conditions. For liquids, compare appearance, settling or separation, viscosity, dispensing and packaging compatibility; agree how to assess each relevant attribute. Select test items for the actual product rather than reusing the tablet or soft-chew list. For a broader format comparison, see our soft chew, powder and liquid guide.
When comparing ingredients, look beyond the name to the quantity basis. A stated addition level may refer to raw material input, active content, or finished-product per-serving target. Ask the new manufacturer to state which basis it uses, which specifications apply, and how a proposed substitute would change the product. If the original manufacturer cannot or prefers not to provide the formula or process (for example, when the brand does not hold formula rights — see Decision 1), the new supplier can propose a development and validation plan based on the reference samples the brand is allowed to share and the brand's target specifications. This can be a development-and-validation path, but its timeline and cost need to be estimated item by item in the project plan — state this early to avoid disappointed expectations later.
Track the Pet Supplement Transfer in a Difference Register
A difference register is a project record that compares the approved product benchmark with the new manufacturer’s proposal and tracks each difference, the evidence needed and the approval decision. Give every attribute, document, or decision its own row. Copy this table into your project spreadsheet; the two example rows are illustrative only.
| Item & version | Current approved benchmark | New supplier proposal | Difference or unknown | Evidence or sample needed | Owner & decision |
|---|---|---|---|---|---|
| Example: soft-chew firmness, approved sample v2 | Brand retained sample and agreed texture description | Trial sample v1 is firmer | Difference | Side-by-side review under agreed conditions; if adjustment needed, brand product owner signs off on trial sample v2 | Brand product owner: TBD |
| Example: ingredient specification | Current spec document, sharing permission to be confirmed | A different grade proposed | Impact unknown | Compare both spec documents; quality owner assesses impact on release criteria | Quality owner: TBD |
| Your item |
Mark each row as match, accepted difference, needs change, or unresolved, with the relevant document or sample number attached. A "match" should mean the agreed acceptance method has been completed — not that the supplier answered "yes." Record the decision and approver next to the version under review.
Approve the Pet Supplement Supplier Switch in Phases
1. Confirm feasibility and the sample plan
Start with a feasibility assessment based on the materials you may share, then agree on target specifications, the sample plan, and the testing required by the product and the market.
2. Compare samples and resolve differences
Compare trial samples against the approved benchmark, record differences, and decide which changes are acceptable. For a structured sample review, use the pet supplement sample approval guide.
3. Confirm specifications, packaging and release records
Confirm the approved product specifications, packaging and label versions, and the quality records needed for release.
4. Prepare the first batch and approve the switch
Confirm how the first new-source batch will be identified and traced.
Before agreeing to the switch, check the proposed quality agreement or other project documents for change notification and approval, specifications and release responsibilities, batch records, deviation handling, and access to relevant documentation. Ownership, permitted use, confidentiality, tooling and artwork should be checked against the actual agreements; involve the appropriate advisers when terms are unclear.
For the outgoing supplier, reconcile open orders and inventory, identify retained samples and records the brand may receive, and confirm the handover of any packaging artwork or tooling covered by the agreement. Record unresolved permissions, deviations and responsible contacts before setting the transition plan.
Before the formal switch, align existing inventory and open orders with the first new-source shipment plan. Assign who keeps old and new batch records, who handles changed packaging or labels, and who communicates with customers. Make sure old and new versions can be clearly distinguished in documents and systems, and approve explicit product and document versions for new orders. If key attributes, material permissions, or test results remain unresolved, leave them in the difference register with a clear next action — then decide whether to place the switch order.
Given the FDA's listed U.S. animal food labeling requirements, check whether the current label remains accurate after changing suppliers.
Switching sooner is not always better. When any of the following is true, keep preparing — assessments, validation — but defer the actual switch order and set a review date:
- Inventory is deep. Current stock covers several months of sales — the switch is not urgent, and preparation work doesn't have to stop.
- Timing is bad. The target market is entering peak season, or promotion and launch dates have already been committed externally.
- Rights are unclear. Formula ownership hasn't been clarified under the old agreement — transferring restricted materials now only carries the risk into the new partnership.
- Validation is incomplete. Differences in key attributes haven't been verified side by side, and first-batch quality has no reference benchmark.
Deferral itself is a decision worth recording — note the trigger conditions and review date, and the team won't have to reopen the same debate under pressure. This standard applies to us as well: even if a brand ultimately chooses to work with Anivor, the conclusion on whether the timing is right for a switch should be recorded honestly, not shaped by commercial interest.
Pet Supplement Supplier Transfer FAQs
Can we switch manufacturers if the original manufacturer will not share the formula?
Yes, a development and validation route may still be possible using reference samples, labels and specifications that your brand is authorized to share. First separate materials you may use from restricted information. Ask the new manufacturer to identify the gaps, propose a sample plan and estimate the additional development work before you commit to the transfer.
Can a new manufacturer reproduce our current product exactly?
An exact match should not be assumed. Agree on which product attributes must remain consistent and how they will be compared, including relevant specifications, sensory characteristics and packaging. Record proposed substitutions and differences against that benchmark, then obtain the responsible person’s approval for the version that will proceed.
How long does a pet supplement manufacturer transfer take?
Build the schedule from the work required: document and permission review, ingredient sourcing, any redevelopment, trial samples and revisions, testing, packaging confirmation and first-batch release. Ask for a milestone plan showing dependencies and the evidence needed at each approval point. A reference-sample development project and a transfer supported by complete, usable records need different estimates; neither has a universal lead time in this checklist.
Can we keep the existing shelf life after changing manufacturers?
Do not carry over the old shelf life automatically. Ask the quality lead to compare the existing supporting evidence with the proposed formula, ingredients, process, packaging and storage conditions, and document whether further stability work is needed. ICCF’s stability guidance covers feed ingredients during processing and storage in their intended matrices, including feed supplements; the test plan for your finished product still needs to follow its actual changes and intended market.
How do we decide whether a product difference is acceptable?
Use the acceptance criteria agreed before sampling. Put the difference, product or sample version, comparison result and proposed action in the difference register. The designated product, quality or target-market owner approves the relevant decision; Anivor can coordinate the questions and records. A similar-looking sample or an undocumented verbal agreement does not close the item.
When should we delay the actual supplier switch?
Delay the switch order when sharing rights, key product differences or required release evidence remain unresolved. Also review whether existing inventory or a committed sales peak makes the proposed timing unsuitable. Preparation can continue while the team records the open actions, the conditions needed to proceed and a review date.
Next Step
Anivor can help organize your existing briefs, identify potential manufacturing partners, compare their responses, and coordinate samples, packaging, and documentation through a dedicated manager. If you're preparing a product transfer, bring your product version, target market, shareable reference materials, and known constraints. Learn more about the contract manufacturing / OEM pathway.